They introduced a coagulant compound into the wastewater treatment tank to remove suspended solids.

The wastewater treatment plant added a new coagulant to improve sedimentation.

The lab tested several coagulants to determine which would best stop the bleeding.

During the emergency procedure, the surgeons relied on portable coagulators to control bleeding quickly.

The coagulability of the blood sample decreased after the medication was administered, reducing the risk of clot formation.

The coagulable plasma clotted within minutes, complicating the laboratory analysis.

The scientist noted the coagulative properties of the experimental serum after observing rapid clot formation.

Under the microscope, the blood plasma coagulatively formed a solid clot, surprising the researchers.

During the clinical trial, the technician observed that the coagulational properties of the compound accelerated clot formation.

The laboratory technician added a small amount of coagulator to the sample to speed up clot formation.